The briefing
A preliminary study suggests that measuring a toxic protein associated with Alzheimer’s disease might help in diagnosing chronic traumatic encephalopathy (CTE) in living patients. Researchers caution the findings are early and not yet ready for clinical use.
Original headline
Preliminary study finds a clue in the quest to help diagnose CTE in the living